FibroBiologics
FBLG
61 hedge funds and large institutions have $16.8M invested in FibroBiologics in 2024 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 19 increasing their positions, 6 reducing their positions, and 7 closing their positions.
217% more repeat investments, than reductions
Existing positions increased: 19 | Existing positions reduced: 6
157% more first-time investments, than exits
New positions opened: 18 | Existing positions closed: 7
22% more funds holding
Funds holding: 50 → 61 (+11)
0.25% more ownership
Funds ownership: 0.53% → 0.78% (+0.25%)
2% less capital invested
Capital invested by funds: $17.2M → $16.8M (-$361K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$2.78M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.83M |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$944K |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$699K |
| 5 |
State Street
Boston,
Massachusetts
|
+$332K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TW
Transform Wealth
Greenwood Village,
Colorado
|
-$668K |
| 2 |
AGM
Alpine Global Management
New York
|
-$120K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$115K |
| 4 |
PWM
Perigon Wealth Management
San Francisco,
California
|
-$84.4K |
| 5 |
Marshall Wace
London,
United Kingdom
|
-$83.3K |
FBLG Hedge Fund Activity: Q3 2024 in Review
61 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in FibroBiologics (FBLG) for Q3 2024, worth a combined $16.8M — down 2.1% from $17.2M a quarter earlier.
Buyers outnumbered sellers: 18 funds opened new FBLG positions and 7 closed out — a net gain of 11 holders — while 19 added to existing stakes and 6 trimmed.
The largest buyer was BlackRock, adding an estimated $2.78M. The largest seller was Transform Wealth, exiting entirely with an estimated $668K sold.
- 61 institutional investors held FibroBiologics (FBLG) as of Q3 2024, up from 50 in Q2 2024.
- Funds reported $16.8M of FibroBiologics stock for Q3 2024, down 2.1% quarter-over-quarter.
- 18 funds opened new FibroBiologics positions in Q3 2024 and 7 closed out, a net change of +11 holders.
- The largest FibroBiologics buyer in Q3 2024 was BlackRock, an estimated $2.78M added.
- The largest FibroBiologics seller in Q3 2024 was Transform Wealth, an estimated $668K sold.
Based on aggregated 13F filings for Q3 2024.